A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes

A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes

Item
http://www.wikidata.org/entity/Q38764824
Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapyβ-Catenin Is a Candidate Therapeutic Target for Myeloid Neoplasms with del(5q).Lenalidomide use in myelodysplastic syndromes: Insights into the biologic mechanisms and clinical applications.Calpain research for drug discovery: challenges and potential.Cereblon: A Protein Crucial to the Multiple Functions of Immunomodulatory Drugs as well as Cell Metabolism and Disease Generation.Promiscuous mechanisms underlie the antitumor effects of thalidomide analogs.Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon.Thalidomide Reduces Hemorrhage of Brain Arteriovenous Malformations in a Mouse Model.The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications.
P2860

A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes

Item
http://www.wikidata.org/entity/Q38764824
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A calcium- and calpain-depende ...... e in myelodysplastic syndromes
@en
type
label
A calcium- and calpain-depende ...... e in myelodysplastic syndromes
@en
prefLabel
A calcium- and calpain-depende ...... e in myelodysplastic syndromes
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
A calcium- and calpain-depende ...... e in myelodysplastic syndromes
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932